Radiation Oncology

Melanoma/Skin   

Questions discussed in this category


Especially in the setting of prior “standard” adjuvant dose and refusal of the patient to undergo more extensive surgery. Do you recommend...

Should concurrent chemotherapy be given? How would you modify the regimen in elderly/frail patients?

These patients are often not surgical candidates, but radiation complications may also be underappreciated.  Do you refer to vascular surgery pri...

Would you recommend axillary dissection, axillary dissection followed by adjuvant radiation, or axillary radiation alone? Does the number of positive ...

Is extrascleral extension or optic nerve invasion an indication?  I can find little in the literature or textbooks discussing this issue, likely ...

What are your dose constraints for treating axillary nodal basin in melanoma with the Ballo protocol 30Gy/5fx?

Should these patients have surgery if resectable? Should RT (SBRT) be directed at metastases during/concurrently with immunotherapy down the road?&nbs...

Would you recommend additional surgery for the violated neck? Or, would you proceed with adjuvant radiation therapy? If so, would you treat ipsilatera...

In this case, I have a patient with widely metastatic cutaneous melanoma (BRAF wild type, NRAS mutated) who is progressing through pembrolizumab and i...

For example, in a patient status-post WLE with a close (2.5 mm) deep margin and negative neck node sampling, would clinical (but not pathologic) ...

For example, for a squamous cell carcinoma of the forearm treated with Mohs surgery with negative margins, are there features that would lead you to e...

Per NCCN, only +/close margins and +PNI are given as indications for adjuvant RT. However, are the presence of other risks factors considered to guide...

If the cyst was encapsulated and completely removed and SCC was found incidentally on final pathology, what are some factors that would influence your...

NCCN lists only substantial perineural invasion.  What about other high-risk adverse features such as histologic subtype, multiple recurrences, d...

Apart from H&N SCC, are there times where adding an extra dose of radiation due to a tx break is appropriate?  Is there a decent equatio...

 How does your fractionation choice change if the lesion is abutting the pleura?

These patients have been largely excluded from these trials.  What if the infection is well controlled?

When elective nodal radiation is recommended, which nodes would you treat (i.e. facial, pre-auricular, peri-parotid, levels I-III, etc.)?

Patient underwent a shave biopsy of a 6x5x2mm preauricular lesion that showed moderatley differentiated sebaceous carcinoma with deep and lateral marg...

How would your management change in an elderly patient with no surgery verus superficial parotidectomy or total parotidectomy? 

Per the NCCN guidelines, in this specific scenario, adjuvant radiation therapy to the locoregional lymph nodes after lymph node dissection is not indi...

In a clinical N0 patient with high risk (large, deeply invasive, poorly differentiated, +PNI, etc) cutaneous SCC of the head and neck, who do you...

Unlike in post-operative cases, you lack detailed pathologic information in this scenario. Do you base your decision on location, size, and/or patholo...

What dose/fractionation would yield the lowest risk of graft failure? Does your treatment management change based of location, ex the ear vs back?

For example, would you recommend treatment of the cervical and posterior occipital lymphatics for a 4 cm lesion deeply invading the posterior ridge of...

How do you decide between plaque brachytherapy and external beam approaches? What dose do you use for plaque brachytherapy? For external beam, what do...

What dose-fractionation schedule and treatment volumes would you utilize for adjuvant radiation therapy status-post total parotidectomy with negative ...

Is there a minimum amount of nodes you would like to be removed before you omit radiation to the neck? Do you consider other factors when deciding whe...

In a patient who already received 13 courses of radiation (with complete response), is there any other effective treatment?

Specifically, the cheek? If so, which nodes should be treated and to what dose?    

Should definitive radiotherapy be used as a standard approach? If so, what are the dose and technique considerations in treating these complicated tum...

If a patient has undergone wide local excision with residual disease, but negative margins, is it safe to observe? If adjuvant treatment is indicated,...

Some medical oncologists tend to hold anticoagulation in patients who develop brain metastases for fear of causing intracranial hemorrhage.  Is t...

Would you treat large/total scalp fields to definitive skin cancer doses? If the patient has a more limited KPS, would you treat sequentially in order...

Would your recommendations change if it was a partial vs complete radiographic response?

How long would you typically wait between date of surgery and initiation of radiation therapy? What factors influence this decision?

If so, how large of a margin would you place on the primary lesion and would you incorporate any adjacent lymph node levels?

For example, if you had an octogenarian with a previously resected squamous cell carcinoma of the skin who presented with metastases to the parotid an...

Do you give a treatment break? Is so, how long should RT be held? Are there skin management techniques to use?

Following Mohs surgery and in the absence of other high risk features, do you offer RT for any PNI?  A single nerve < 0.1 mm? A single ne...

Would you be comfortable with 55Gy in 20 fractions around the optic nerves and brainstem, or would you treat with a more protracted fractionation? Do ...

Would re-irradiation be an appropriate option? What dose/field would you incorporate? If treating with standard fractionation, would you take the enti...

If the patient is a poor surgical candidate and is a symptomatic, can he or she live with this?

I have seen some patients who may undergo large complex closures (sometimes as a separate procedure) for smaller lesions with resulting scars that sig...

Is there any consensus regarding the optimal RT dose, fractionation, and timing to the best abscopal response? What is the optimal metastatic site to ...

For example, if a 5 x 5 cm squamaous cell carcinoma with deep invasion has been resected via Mohs with negative margins, will your PTV include the ent...

Is modern surgical/reconstruction treatment superior to radiation therapy? If contact brachytherapy or superficial (orthovoltage) therapy isnt possib...

Is the surrounding erythema as part of the GTV so that the margin is placed around the erythema rather than around the gross lesion only?

Assume all other options have been exhausted or are not feasible (e.g. systemic treatments, medically inoperable, etc.). Is there a BED or EQD2 that y...

What is the preferred dose, fractionation, and role of concurrent chemo? 

Do you hypofractionate or add any concurrent systemic therapy? 

Even though data from TROG 02.01 showed 52% decrease in LR, I've heard some argue that toxicity is increased and that "it damages the blood vessels an...


Papers discussed in this category


Blood, 2015 May 18

Cancer, 1995 May 1

JAMA Dermatol, 2016-09-01

Ann Surg Oncol, 2003 May

Am. J. Surg., 2001-12-01

World J Surg, 1992 Mar-Apr

Cancer, 2005-10-01

Radiother Oncol, 2014 Jan

Radiat Oncol, 2015-09-21

Med Dosim, 2013 Summer

Radiother Oncol, 1989-02-01

Int J Radiat Oncol Biol Phys, 2016 Jun 1

Radiother Oncol, 2002-07-01

Radiother Oncol, 2017 Oct

Head Neck, 2011-12-01

Int. J. Radiat. Oncol. Biol. Phys.,

Int. J. Radiat. Oncol. Biol. Phys.,

J. Clin. Oncol., 2017 Dec 28

Lancet, 2017 Oct 21

J. Clin. Oncol.,

Int J Radiat Oncol Biol Phys, 2009 Apr 1

N Engl J Med, 2012 Mar 8

Pract Radiat Oncol, 2017 Apr 18

PLoS One, 2016

Int. J. Radiat. Oncol. Biol. Phys.,

Lancet Oncol., 2012 May 09

J Surg Oncol, 2018 Dec 18

Clin. Cancer Res., 2017 Jul 27

Ther Adv Med Oncol, 2018 Apr 11

Int J Radiat Oncol Biol Phys, 2002 Mar 15

Lancet Oncol., 2014-11-01

Ann. Oncol., 2011 Jul 12